Perspectives on immunotherapy utilization for hepatobiliary cancers in the United States

摘要：

Strategies involving immunotherapy and targeted therapies are emerging in the last years as valuable options for patients with hepatobiliary cancer (HBC) including hepatocellular carcinoma (HCC), gallbladder cancer (GBC), intrahepatic cholangiocarcinoma (ICC), and extrahepatic cholangiocarcinoma (ECC).

所属期刊栏目：9

在线出版日期：2020-08-20（万方平台首次上网日期，不代表论文的发表时间）

页数：共4页

页码：501-504